Last updated: March 2, 2021
Sponsor: Deutsches Herzzentrum Muenchen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Valve Disease
Treatment
N/AClinical Study ID
NCT04223713
77/19-S
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age > 50 years
- Documented symptomatic moderate or greater aortic stenosis or severe aorticinsufficiency
- Aortic annulus > 19 mm
- Written informed consent of the patients.
Exclusion
Exclusion Criteria:
- Concomitant intervention of the aortic root, ascending aorta or aortic arch
- Concomitant valve surgery
- Emergency surgery for any reason
- Neurological events (i.e. stroke, TIA) within the previous 6 months
- Coagulation disorders (including thrombocytopenia < 100.000/ml)
- Porcelain aorta/severe calcification of the ascending aorta
- Active endocarditis or other active systemic infections
- Participating in another trial that may influence the outcome of this trial
- Pregnancy
- Dual antiplatelet therapy
- Previous cardiac surgery (excluding percutaneous procedures)
- Contraindication for MRI- examinations
Study Design
Total Participants: 30
Study Start date:
January 14, 2020
Estimated Completion Date:
August 31, 2021
Study Description
Connect with a study center
Deutsches Herzzentrum Muenchen, Department of Cardiovascular Surgery
Munich, 80636
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.